In this issue:
Glucocorticoids: no benefits with tofacitinib in RA
Atacicept looks promising in SLE
Ixekizumab: long-term efficacy and safety in PsA
Opioid analgesic use in patients with AS
Long-term efficacy and safety of baricitinib in RA
Pain sensitisation and disease activity in RA
A high burden of disability in early dcSSc
Rheumatic immune-related AEs in ICI users
Rituximab may improve Sjögren’s syndrome
Arthritis prevalence in the US exceeds earlier estimates
Please login below to download this issue (PDF)